- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02982174
Evaluation of the Signal to Noise Ratio at Various Retinal Layers
June 6, 2022 updated by: Topcon Medical Systems, Inc.
Evaluation of the Signal to Noise Ratio at Various Retinal Layers in Spectral Domain Optical Coherence Tomography (SD OCT) Compared to Swept Source Optical Coherence Tomography (SS OCT)
Compare the signal to noise ratio of each device at various retinal layers.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Compare the signal to noise ratio of each device (SD OCT and SS OCT) at various retinal layers from the same group of subjects
Study Type
Observational
Enrollment (Actual)
15
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Oakland, New Jersey, United States, 07436
- Topcon Medical Systems Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
30 subjects willing to participate in this study.
Description
Inclusion Criteria:
- Male or female patients > 18 years old who have full legal capacity to volunteer on the date the informed consent is signed.
- Subjects who can follow the instructions by the clinical staff at the clinical site, and can attend examinations on the scheduled examination date.
- Subjects who agree to participate in the study.
Exclusion Criteria:
- History of cataract or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device.
- Fixation problems which may prevent obtaining good quality images in either eye.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Normal Eyes
Subjects with no known ocular diseases will be imaged on the 3D OCT-1 Maestro and DRI OCT Triton
|
Image acquisition of the posterior surface of the eye
Image acquisition of the posterior surface of the eye
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Signal to noise ratio between SD OCT and SS OCT
Time Frame: 5 minutes
|
5 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2016
Primary Completion (Actual)
December 1, 2016
Study Completion (Actual)
January 1, 2017
Study Registration Dates
First Submitted
November 29, 2016
First Submitted That Met QC Criteria
November 30, 2016
First Posted (Estimate)
December 5, 2016
Study Record Updates
Last Update Posted (Actual)
June 8, 2022
Last Update Submitted That Met QC Criteria
June 6, 2022
Last Verified
June 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Topcon-601-2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Eyes
-
Topcon Medical Systems, Inc.Completed
-
Topcon Medical Systems, Inc.Withdrawn
-
Alcon ResearchCompleted
-
Intalight, IncIllinois College of OptometryRecruitingNormal Healthy Eyes | Eyes With Corneal Abnormality | Glaucoma Patients | Retina PatientsUnited States
-
University of HoustonNot yet recruitingNormal Healthy Eyes
-
Freedom MeditechCompleted
-
Centervue SpARecruitingHealthy EyesUnited States, Australia, Switzerland
-
Intelon Optics, IncCompletedCorneal Crosslinking | Healthy Eyes | Corneal TransplantUnited States
-
Topcon Medical Systems, Inc.Completed
Clinical Trials on 3D OCT-1 Maestro
-
Topcon Medical Systems, Inc.Completed
-
Topcon Medical Systems, Inc.CompletedSubjects Presenting With Normal EyesUnited States
-
Topcon Medical Systems, Inc.CompletedNormal Healthy Subjects With No Known Ocular Diseases | Glaucomatous Eyes | Eyes With Retinal DiseasesUnited States
-
Crystalvue Medical CoporationCompletedGlaucoma | Cornea | Retinal Disease | Normal SubjectTaiwan
-
Topcon Medical Systems, Inc.Completed
-
Medical University of ViennaNot yet recruiting
-
Topcon Medical Systems, Inc.Withdrawn
-
University of California, IrvineBeckman Laser Institute University of California Irvine; VA Long Beach Healthcare...Withdrawn
-
Ammar AlubaydiCompleted
-
University of MalayaCompletedPostoperative Delirium | Diagnosis, Psychiatric